Activin type II receptor signaling in cardiac aging and heart failure.
Saved in:
| Title: | Activin type II receptor signaling in cardiac aging and heart failure. |
|---|---|
| Authors: | Roh JD; Corrigan Minehan Heart Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA., Hobson R; Corrigan Minehan Heart Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA., Chaudhari V; Corrigan Minehan Heart Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA., Quintero P; Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA., Yeri A; Corrigan Minehan Heart Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA., Benson M; Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA., Xiao C; Corrigan Minehan Heart Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA., Zlotoff D; Corrigan Minehan Heart Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA., Bezzerides V; Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA., Houstis N; Corrigan Minehan Heart Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA., Platt C; Corrigan Minehan Heart Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA., Damilano F; Corrigan Minehan Heart Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA., Lindman BR; Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN 37203, USA., Elmariah S; Corrigan Minehan Heart Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA., Biersmith M; Division of Cardiovascular Medicine, Wexner Medical Center, Ohio State University, Columbus, OH 43210, USA., Lee SJ; The Jackson Laboratory, Farmington, CT 06032, USA.; Department of Genetics and Genome Sciences, University of Connecticut School of Medicine, Farmington, CT 06032, USA., Seidman CE; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA.; Howard Hughes Medical Institute, Chevy Chase, MD 20815, USA.; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA 02114, USA., Seidman JG; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA., Gerszten RE; Division of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA., Lach-Trifilieff E; Novartis Institutes for Biomedical Research, CH-4056 Basel, Switzerland., Glass DJ; Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA., Rosenzweig A; Corrigan Minehan Heart Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. arosenzweig@partners.org. |
| Source: | Science translational medicine [Sci Transl Med] 2019 Mar 06; Vol. 11 (482). |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1946-6242 |
|---|---|
| DOI: | 10.1126/scitranslmed.aau8680 |
